https://www.zacks.com/stock/news/2269968/aclaris-therapeutics-acrs-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2269968
May 07, 2024 - Aclaris (ACRS) delivered earnings and revenue surprises of 14.29% and 20.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
zc:-7181355849469219805
0
https://seekingalpha.com/article/4682593-acres-commercial-realty-the-discount-to-book-value-is-too-much?source=feed_all_articles
Apr 07, 2024 - ACRES Commercial Realty's focus on multifamily loans means it's less exposed to office real estate. Learn more about ACR stock and its preferreds.
0
sa:7969477274810399230
0
https://www.zacks.com/stock/news/2251145/are-medical-stocks-lagging-aclaris-therapeutics-acrs-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2251145
Apr 05, 2024 - Here is how Aclaris Therapeutics (ACRS) and Aldeyra Therapeutics, Inc. (ALDX) have performed compared to their sector so far this year.
zc:-6580098266256650058
0
https://www.zacks.com/stock/news/2225477/are-medical-stocks-lagging-aclaris-therapeutics-acrs-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2225477
Feb 13, 2024 - Here is how Aclaris Therapeutics (ACRS) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.
zc:7558093069990750761
0
https://www.washingtonpost.com/business/interactive/2024/look-around-33-acre-horse-farm-loudoun-county-va/
Feb 08, 2024 - The property’s main house is over 200 years old.
0
wp:-6812342133255491227
0
https://www.zacks.com/stock/news/2211548/aclaris-acrs-stock-rises-on-appointment-of-new-interim-ceo?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2211548
Jan 17, 2024 - Aclaris (ACRS) appoints Neal Walker as interim CEO after current CEO, Douglas Manion, steps down from his role. Shares rise.
zc:-6600895409325080549
0
https://www.zacks.com/stock/news/2205668/are-medical-stocks-lagging-aclaris-therapeutics-acrs-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2205668
Jan 04, 2024 - Here is how Aclaris Therapeutics (ACRS) and Regeneron (REGN) have performed compared to their sector so far this year.
zc:8589283993829156293
0
https://www.zacks.com/stock/news/2200830/zacks-industry-outlook-highlights-ladder-capital-mfa-financial-and-acres-commercial-realty?cid=CS-ZC-FT-press_releases-2200830
Dec 21, 2023 - Ladder Capital, MFA Financial and ACRES Commercial Realty have been highlighted in this Industry Outlook article.
zc:-6393370879638413202
0
https://www.zacks.com/stock/news/2199306/here-is-why-bargain-hunters-would-love-fast-paced-mover-acres-commercial-acr?cid=CS-ZC-FT-tale_of_the_tape|fast_paced_momentum_at_a_bargain-2199306
Dec 18, 2023 - ACRES Commercial (ACR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
zc:6433414652952852965
0